Sun Pharma to Pay Pfizer $550 Million

Source: PharmaManufacturing.com

Jun 13, 2013

Bloomberg.com

Sun Pharmaceuticals Ltd. is India's largest drugmaker according to market value, but shares have declined almost 3 percent. This drop is a result of Sun Pharma's patent litigation settlement with Pfizer Inc. Sun Pharma was found to have sold Pfizer's heartburn drug Protonix without authorization and has agreed to pay $550 million as a result. Read the full story.
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments